18:30
2026-08-31
mercurynews.com
artificial-intelligence
This vaccine reduces risk of melanoma coming back. Can it work for other cancers?
Moderna and Merck announced that their personalized mRNA cancer vaccine, Intismeran Autogene, combined with the immunotherapy Keytruda, reduced the risk of melanoma recurrence by 49% within five years…